Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou Qianyuan Baoling Pharmaceutical Co., Ltd., a subsidiary of ShanXi C&Y Pharmaceutical Group, is a Chinese pharmaceutical company specializing in maternal and child health, cardiovascular, and metabolic treatments. Founded in 1994 and based in Hangzhou, the company is well-known for its "Pollenin" (保灵) brand, which has provided pregnancy health products like folic acid supplements since 1985. Its product portfolio includes a range of chemical drugs such as perindopril amlodipine for hypertension, rosuvastatin for hypercholesterolemia, and ebastine for allergies. The company operates modern manufacturing facilities and focuses on the development and commercialization of high-quality generic medications and nutritional supplements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hangzhou Qianyuan Baoling Pharmaceutical.